Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Oppenheimer Maintains Outperform on Utz Brands, Lowers Price Target to $20

Oppenheimer maintains Utz Brands (NYSE:UTZ) with a Outperform and lowers the price target from $23 to $20.

byBenzinga Newsdesk

November 2, 2021

1 minute read

Oppenheimer maintains Utz Brands (NYSE:UTZ) with a Outperform and lowers the price target from $23 to $20.

Cowen & Co. Downgrades Northrop Grumman to Market Perform, Announces $478 Price Target

By Benzinga Newsdesk

Today, 7:03 AM

Cowen & Co. analyst Cai Rumohr downgrades Northrop Grumman (NYSE:NOC) from Outperform to Market Perform and announces $478 price target.

NOC

NeuroMetrix’s Quell Neuromodulator Will Be Tested In Long COVID-19 Syndrome

By Vandana Singh

Today, 7:03 AM

NeuroMetrix Inc's (NASDAQ: NURO) Quell wearable neuromodulation technology will be evaluated for fibromyalgia-like syndrome in individuals with

NURO

Global
News

‘Toyota CEO: Going All-EV Could Cost Japan Millions Of Jobs’ – InsideEVs

By Benzinga Newsdesk

Today, 7:03 AM

https://insideevs.com/news/534262/all-ev-plans-threaten-japan/

Schlumberger Q4 EPS $0.71 Beats $0.68 Estimate, Sales $7.90B Beat $7.81B Estimate

By Bill Haddad

Today, 7:03 AM

Schlumberger (NYSE:SLB) reported quarterly earnings of $0.71 per share which beat the analyst consensus estimate of $0.68 by 4.41 percent. This is a 73.17 percent increase over earnings of $0.41 per share from the same

SLB

Oppenheimer Maintains Outperform on Utz Brands, Lowers Price Target to $20

Related Posts

Cowen & Co. Downgrades Northrop Grumman to Market Perform, Announces $478 Price Target

NeuroMetrix’s Quell Neuromodulator Will Be Tested In Long COVID-19 Syndrome

‘Toyota CEO: Going All-EV Could Cost Japan Millions Of Jobs’ – InsideEVs

Schlumberger Q4 EPS $0.71 Beats $0.68 Estimate, Sales $7.90B Beat $7.81B Estimate